Relationship between serum levels of interleukin 6, various disease parameters, and malnutrition in patients with esophageal squamous cell carcinoma

Cancer Research

Volumn 56, Issue 12, 1996, Pages 2776-2780

  Oka, Masaaki ^a   Yamamoto, Kohtaro ^a   Takahashi, Mutsuo ^a   Hakozaki, Michinori ^b   Abe, Toshihiro ^a   Iizuka, Norio ^a   Hazama, Shoichi ^a   Hirazawa, Katsutoshi ^a   Hayashi, Hiroto ^a   Tangoku, Akira ^a   Hirose, Kunitaka ^b   Ishihara, Tokuhiro ^a   Suzuki, Takashi ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KUREHA CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; MESSENGER RNA;

ADULT; AGED; ARTICLE; CACHEXIA; CANCER INVASION; DIAGNOSTIC VALUE; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NUTRITION DISORDERS; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-6; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 9344266888     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Katlic, M. R., Wilkins, E W., and Grillo, H C. Three decades of treatment of esophageal squamous carcinoma at the Massachusetts General Hospital. J Thorac. Cardiovasc Surg , 99 929-938, 1990
2. Ellis, F H , Jr., Gibb, S. P., and Watkins, E., Jr. Esophagogastrectomy: a safe, widely applicable, and expenditious form of palliation for patients with carcinoma of the esophagus and cardia Ann Surg , 198: 531-539, 1983
3. Earlam, R., and Cunha-Melo, T R Oesophageal squamous cell carcinoma: II. A critical review of radiotherapy. Br. J. Surg , 67: 457-461, 1980.
4. Kishimoto, T The biology of interleukin-6. Blood. 74. 1-10, 1989
5. Muraguchi, A , Kishimoto, T., Miki, Y., Kuritani, T , Kaieda, T., Yoshizaki, K., and Yamamura, Y T cell-replacing factor (TRF)-induced IgG secretion in human B blastoid cell line and demonstration of acceptors for TRF. J Immunol., 127: 412-416, 1981
6. Lotz, M., Jink, F , Kabouridis, P , Tsoukas, S , Hirano, T., Kishimoto, T , and Carson, D. A. B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes J. Exp. Med , 167: 1253-1258, 1988.
7. Okuda, M., Kitahara, M , Kishimoto, S , Matsuda, T., Hirano, T., and Kishimoto T. IL-6/BSF-2 functions as a killer helper factor in the in vtiro induction of cytotoxic T cells. J Immunol., 141: 1543-1549, 1988
8. Gallagher, G , Stimson, W. H., Findlay, J., and Al-Azzawi, F. Interleukin-6 enhances the induction of human lymphokine-activated killer cells. Cancer Immunol. Immunother., 31 49-52, 1990.
9. Luger, T. A., Kruttman, J , Kirnbauer, R , Urbanski, R. A , Schwartz, T., Klappacher, G. Kock, A., Micksche, M , Malejczyk, J , Schauer, E., May, T L., and Sehgal, P. B. INF/IL-6 augments the activity of human natural killer cells J. Immunol., 143: 1206-1209, 1989.
10. Gauidie, J., Richards, C , Harnish, D , Lansdorp, P., and Baumann, H. Interferon beta 2/BSF2 shares identity with monocyte derived hepatocyte stimulating factor and regulates the major acute phase protein in liver cells. Proc. Natl. Acad Sci USA, 84. 7251-7255, 1987.
11. Castell, J V , Gomez-Lechon, M. J. David, M., Horano, T., Kishimoto, T, and Heinrich, P C. Acute phase response of human hepatocytes: regulation of acute phase protein synthesis by IL-6 Hepatology, 12: 1179-1186, 1990
12. Strassmann, G., Jacob, C. O., Evans, R., Beall, D., and Fong, M. Mechanism of experimental cancer cachexia Interaction between mononuclear phagocytes and colon-26 carcinoma and its relevance to IL-6-mediated cancer cachexia. J. Immunol., 148: 3674-3678, 1992.
13. Tabibzadeh, S S , Poubouridis, D., May, L T., and Sehgal, P. B. Interleukin-6 immunoreactivity in human tumors. Am J. Pathol., 135, 427-433, 1989.
14. Kawano, M , Hirano, T., Matsuda, T., Taga, T., Hom, Y., Iwato, K., Asaoku, H., Tang, B., Tanabe, O , Tanaka, H , Kuramoto, A , and Kishimoto, T Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature (Lond.), 332: 83-85, 1988.
15. Miki, S , Iwano, M , Miki, Y., Yamamoto, M., Tang, B., Yokokawa, K , Sonoda, T., Hirano, T., and Kishimoto, T. Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas. FEBS Lett., 250: 607-610, 1989.
16. Lee, J. D , Sievers, T. M., Skotzko, M., Chandler, C. F., Morton, D. L. McBride, W. H , and Economou, J. S. Interleukin-6 production by human melanoma cell lines. Lymphokine Cytokme Res., 11: 166, 1992.
17. Meir, E V., Sawamura, Y., Diserens, A., Hamou, M., and Tribolet. N. Human glioblastoma cells release interleukin 6 in vivo and in vitro. Cancer Res., 50. 6683-6688, 1990
18. Takizawa, H. Ohtoshi, T., Ohta, K , Yamashita, N., Hirohata, S., Hirai, K., Hiramatsu, K., and Ito, K. Growth inhibition of human lung cancer cell lines by interleukin 6 in vitro. a possible role in tumor growth via an autocrine mechanism. Cancer Res., 53: 4175-4181, 1993.
19. Watson, J. M., Sensintaffar, J. L , Berek, J. S., and Martinez-Maza, O Constitutive production of interleukin 6 by ovarian cancer cell lines and by primary ovarian tumor cultures. Cancer Res., 50: 6959-6965, 1990.
20. Eustace, D , Han, X., Goading, R., Rowbottom, A , Riches, P., and Heyderman, E. Interleukin-6 (IL-6) functions as an autocrine growth factor in cervical carcinomas in vitro Gynecol. Oncol , 50 151-159, 1993.
21. Blay, J-Y., Negner, S., Combaret, V., Attali, S , Goillot, E , Merrouche, Y., Mercatello, A., Ravault, A., Tourani, J-M., Moskovtchenko, J-F., Philip, T., and Favrot, M Serum level of interleukin 6 as a prognostic factor in metastatic renal cell carcinoma Cancer Res., 52: 3317-3322, 1992.
22. Berek, J. S., Chung, C , Kaldi, K., Watson, J. M., Knox, R. M., and Martinez-Maza, O. Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer. Am. J. Obstet. Gynecol., 164. 1038-1043, 1991.
23. Harmanek, P., and Sobin, L H. (eds.) International Union Against Cancer; TNM Classification of Malignant Tumours, 4th ed. Berlin. Springer-Verlag, 1992.
24. Kobayashi, H., Takeda, K., Miyano, K., Yamane, T., and Sato, J Growth of hepatoma cell lines with differentiated functions in chemically defined medium. Cancer Res., 42: 3858-3863, 1982.
25. Lu, C., and Kerbel, R S. Interleukin-6 undergoes transition from paracrine growth inhibitor to aulocrme stimulator during human melanoma progression. J. Cell Biol , 120: 1281-1288, 1993.
26. Tanner, J , and Tosato, G Impairment of natural killer functions by interleukin 6 increases lymphoblastoid cell tumongenicity in athymic mice J. Clin. Invest., 88: 239-247, 1991
27. Sporn, M B., and Roberts, A B. Autocrine growth factor and cancer. Nature (Lond.), 313: 745-747, 1985
28. Strassmann, G., Fong, M , Kenney, J. S , and Jacob, C O Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J. Clin. Invest., 89. 1681-1684, 1992
29. Fearon, K. C H , McMillan, D. C , Preston, T. Winstanley, F. P., Cruickshank, A. M , and Shenkin, A Elevated circulating interleukin-6 is associated with an acute-phase response but reduced fixed hepatic protein synthesis in patients with cancer Ann. Surg., 213: 26-31, 1991
30. Falconer, J S., Fearon, K C., Plester, C E , Ross. J A , and Carter, D C Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer. Ann Surg., 219: 325-331, 1994.
31. Munck-Wikland, E. Kuylenstierna, R , Wahren, B , Lindholm, J , and Haglund, S. Tumor markers carcinoembryomc antigen. CA 50. and CA 19-9 and squamous cell carcinoma of the esophagus. Cancer (Phila.), 62. 2281-2286, 1988.
32. Kato, H , and Tongoe, T. Radioimmunoassay for tumor antigen of human squamous cell carcinoma. Cancer (Phila), 40 1621-1628, 1977.
33. Ikeda, K. Clinical and fundamental study of a squamous cell carcinoma related antigen (SCC-RA) for esophageal squamous cell carcinoma. J. Jpn. Surg Soc , 92: 387-396, 1990 (in Japanese)